Veralipride is a benzamide neuroleptic medicine indicated in the treatment of vasomotor symptoms associated with the menopause. It was first authorised for use in 1979. Veralipride was withdraw from the market in 2007. References: Valencia MH, Arias Mde J, González CC, Marín IH, González JH, Campos ER, Rodríguez MA, Alvarez IM, Vargas MA, Flores JB, Haro SS, Bonilla MC, Escudero RB, Campero RA. Safety of veralipride for the treatment of vasomotor symptoms of menopause. Menopause. 2014 May;21(5):484-92. doi: 10.1097/GME.0b013e3182a46dcb. PubMed PMID: 24065139.

纯度：≥98%

CAS：66644-81-3